ClinicalTrials.Veeva

Menu

Remission in Rheumatoid Arthritis in the Asian-Pacific Region

P

Peking University

Status

Unknown

Conditions

Rheumatoid Arthritis

Treatments

Other: observational study

Study type

Observational

Funder types

Other

Identifiers

NCT03365856
PKUPH-R-RA

Details and patient eligibility

About

This study is the multi-center, open and cross-sectional study of RA remission in Asia Pacific region. The objectives is to explore remission rate of RA patients in different countries in the Asian-Pacific area using different criteria of remission (DAS28, CDAI, SDAI, ACR/EULA remission criteria, RAPID3 and Clin28) and investigate the associated factors of remission in RA patients.

Enrollment

1,500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • RA patients fulfilled the American College of Rheumatology 1987 criteria or the 2010 ACR/EULAR classification criteria.
  • Patients aged > 18 years.

Exclusion criteria

  • No

Trial design

1,500 participants in 1 patient group

RA patients
Description:
As routinary clinical practice and observational study
Treatment:
Other: observational study

Trial contacts and locations

0

Loading...

Central trial contact

Ru Li, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems